Chemokine-Mediated Robust Augmentation of Liver Engraftment: A Novel Approach

  • Joshi M
  • Oltean M
  • Patil P
  • et al.
5Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Effective repopulation of the liver is essential for successful clinical hepatocyte transplantation. The objective was to improve repopulation of the liver with human hepatocytes using chemokines. We used flow cytometry and immunohistochemistry assays to identify commonly expressed chemokine receptors on human fetal and adult hepatocytes. The migratory capacity of the cells to various chemokines was tested. For in vivo studies, we used a nude mouse model of partial hepatectomy followed by intraparenchymal injections of chemokine ligands at various concentrations. Human fetal liver cells transformed with human telomerase reverse transcriptase were used for intrasplenic cell transplantation. Repopulation and functionality were assessed 4 weeks after transplantation. The receptor CXCR3 was commonly expressed on both fetal and adult hepatocytes. Both cell types migrated efficiently toward corresponding CXC chemokine ligands 9, 10, and 11. In vivo, animals injected with recombinant chemokines showed the highest cell engraftment compared with controls (p

Cite

CITATION STYLE

APA

Joshi, M., Oltean, M., Patil, P. B., Hallberg, D., Kleman, M., Holgersson, J., … Sumitran-Holgersson, S. (2015). Chemokine-Mediated Robust Augmentation of Liver Engraftment: A Novel Approach. Stem Cells Translational Medicine, 4(1), 21–30. https://doi.org/10.5966/sctm.2014-0053

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free